Xencor Inc (XNCR) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Xencor Inc · Health Care · ref. ETF XLV · 50 calls · price $28.88
What the company does: Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.
📈 Xencor Inc (XNCR) stock price
$28.88+258.8% over range
Aug 28, 25low $8.05 · high $29.3Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
80% recommend buying · 5 analysts
📊 JPI status :
Xencor Inc is part of our 2026 selection (JPI Fair + JPI Risk +), bought at the start of the year and tracked live. It no longer shows in today's ranking: its target has been reached, there is no gap left. See the 2026 selection and its performance →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 XNCR price target & analyst consensus — price $28.88
The price target · all analysts combined (5 targets)
Highest target · 1 firm of 5$44+52.4%
Median target · of 5 targets$27-6.5%
Lowest target · 1 firm of 5$14-51.5%
Current price$28.88
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
240%
$30 ↔ $44
Below
360%
$14 ↔ $27
⏳ Targets haven't kept up with the price. 80% of ratings say “Buy”, yet 3 of 5 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 XNCR price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on XNCR most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in XNCR? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Xencor Inc? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on XNCR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Leerink Swann | 100% | +97.5% | 2 |
| Guggenheim ↗ | 67% | +29.7% | 3 |
| Piper Sandler ↗ | 67% | -4.6% | 3 |
| SVB Leerink | 50% | -0.3% | 4 |
| HC Wainwright & Co. ↗ | 50% | -11.3% | 2 |
| Wedbush ↗ | 43% | +17.1% | 7 |
| Canaccord Genuity ↗ | 40% | +5.9% | 5 |
| Wells Fargo ↗ | 33% | +51.1% | 3 |
| RBC Capital ↗ | 33% | +8.7% | 9 |
| Mizuho ↗ | 33% | -18.3% | 3 |
📊 What $1,000 invested in Xencor Inc would be worth › open the full page
In short — $1,000 invested in Xencor Inc 10 years ago would be worth $1,023 today, i.e. +0%/yr on average. Best year: 2016 (+80%), worst: 2022 (-35%). Price performance, excluding dividends.
If I'd invested $1,000 in Xencor Inc
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $651 | -35% |
| 3 years ago | $574 | -43% |
| 5 years ago | $343 | -66% |
Return by year (Xencor Inc)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -2% | $976 (-2%) |
| 2025 | -33% | $651 (-35%) |
| 2024 | +8% | $704 (-30%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Xencor Inc
Loading news…
📋 All analyst calls on XNCR
Filtered on — · ✕ show all
RBC Capital ↗
Aug 6, 26
▲ Outperform · 🎯$20
Price at call : $20.81 — upside -4%
Today : $28.88 — upside -31%
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Outperform · 🎯$30
Price at call : $20.81 — upside +44%
Today : $28.88 — upside +4%
🎯 on XNCR : 40% (5 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Cantor Fitzgerald ↗
Aug 6, 26
▲ Overweight · 🎯$44
Price at call : $20 — upside +120%
Today : $28.88 — upside +52%
🎯 on XNCR : no call matured yet · 📊 on Health : 50.6% · +13.8% (166 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Outperform · 🎯$26
Price at call : $20.21 — upside +29%
Today : $28.88 — upside -10%
🎯 on XNCR : 40% (5 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Truist Securities ↗
Jul 7, 26
▲ Buy · 🎯$27
Price at call : $15.67 — upside +72%
Today : $28.88 — upside -7%
🎯 on XNCR : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
■ Neutral neutral · not a buy · 🎯$14
Price at call : $12.44 — gap to target +13%
Today : $28.88 — gap to target -52%
🎯 on XNCR : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
■ Neutral neutral · not a buy · 🎯$13
Price at call : $11.89 — gap to target +9%
Today : $28.88 — gap to target -55%
🎯 on XNCR : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Mar 24, 27
matures : Mar 24, 27
▲ Overweight · 🎯$27
Price at call : $12.77 — upside +111%
Today : $28.88 — upside -7%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
See the other 42 calls, newest to oldest
▲ Overweight · 🎯$26
Price at call : $15.69 — upside +66%
Today : $28.88 — upside -10%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Truist Securities ↗
Nov 24, 25
▲ Buy · 🎯$29
Price at call : $17.26 — upside +68%
Today : $28.88 — upside +0%
🎯 on XNCR : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 24, 26
matures : Nov 24, 26
▲ Overweight · 🎯$18
Price at call : $13.9 — upside +29%
Today : $28.88 — upside -38%
🎯 on XNCR : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
RBC Capital ↗
Nov 6, 25
▲ Outperform · 🎯$19
Price at call : $13.9 — upside +37%
Today : $28.88 — upside -34%
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Cantor Fitzgerald ↗
Nov 6, 25
▲ Overweight · 🎯$42
Price at call : $13.9 — upside +202%
Today : $28.88 — upside +45%
🎯 on XNCR : no call matured yet · 📊 on Health : 50.6% · +13.8% (166 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Overweight · 🎯$23
Price at call : $14.67 — upside +57%
Today : $28.88 — upside -20%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
RBC Capital ↗
Oct 27, 25
▲ Outperform · 🎯$18
Price at call : $14.25 — upside +26%
Today : $28.88 — upside -38%
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
B of A Securities ↗
Sep 3, 25
■ Neutral neutral · not a buy · 🎯$12
Price at call : $8.37 — gap to target +43%
Today : $28.88 — gap to target -58%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Sep 3, 26
matures : Sep 3, 26
▲ Outperform · 🎯$26
Price at call : $8.33 — upside +212%
Today : $28.88 — upside -10%
🎯 on XNCR : 40% (5 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Sep 2, 26
matures : Sep 2, 26
RBC Capital ↗
Aug 21, 25
▲ Outperform · 🎯$15
Price at call : $8.41 — upside +78%
Today : $28.88 — upside -48%
Expected +78% · Actual +245% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+244.8%
stock +245% · XLV +26%
matured Aug 21, 26
Wells Fargo ↗
Aug 7, 25
▲ Overweight · 🎯$27
Price at call : $7.23 — upside +273%
Today : $28.88 — upside -7%
Expected +273% · Actual +198% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 33% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+198.5%
stock +198% · XLV +29%
matured Aug 7, 26
▲ Outperform · 🎯$26
Price at call : $7.32 — upside +255%
Today : $28.88 — upside -10%
Expected +255% · Actual +184% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 40% (5 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+184.3%
stock +184% · XLV +28%
matured Aug 7, 26
▼ Underweight · 🎯$6
Price at call : $8.33 — upside -28%
Today : $28.88 — upside -79%
Expected -28% · Actual +54% · Reason (≤ −15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
-53.5%
stock +54% · XLV +8%
matured May 8, 26
William Blair ↗
Apr 21, 25
▲ Outperform
Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 100% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)
+20.7%
stock +21% · XLV +8%
matured Apr 21, 26
Wells Fargo ↗
Feb 28, 25
▲ Overweight · 🎯$33
Price at call : $14.46 — upside +128%
Today : $28.88 — upside +14%
Expected +128% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 33% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
-14.9%
stock -15% · XLV +6%
matured Feb 28, 26
Wells Fargo ↗
Dec 12, 24
▲ Overweight · 🎯$37
Price at call : $24.03 — upside +54%
Today : $28.88 — upside +28%
Expected +54% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 33% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
-30.1%
stock -30% · XLV +11%
matured Dec 12, 25
Piper Sandler ↗
Dec 2, 24
▲ Overweight · 🎯$30
Price at call : $26.84 — upside +12%
Today : $28.88 — upside +4%
Expected +12% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 45.8% · +6.9% (249 calls)
-40.4%
stock -40% · XLV +5%
matured Dec 2, 25
BMO Capital ↗
Nov 8, 24
▲ Outperform · 🎯$34
Price at call : $23.31 — upside +46%
Today : $28.88 — upside +18%
Expected +46% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (4 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-41.1%
stock -41% · XLV -1%
matured Nov 8, 25
▲ Overweight · 🎯$28
Price at call : $23.62 — upside +19%
Today : $28.88 — upside -3%
Expected +19% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-41.8%
stock -42% · XLV -2%
matured Nov 7, 25
RBC Capital ↗
Sep 26, 24
▲ Outperform · 🎯$34
Price at call : $20.25 — upside +68%
Today : $28.88 — upside +18%
Expected +68% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-43.0%
stock -43% · XLV -11%
matured Sep 26, 25
BMO Capital ↗
Aug 6, 24
▲ Outperform · 🎯$32
Price at call : $15.7 — upside +104%
Today : $28.88 — upside +11%
Expected +104% · Actual -53% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (4 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-53.4%
stock -53% · XLV -12%
matured Aug 6, 25
RBC Capital ↗
Aug 6, 24
▲ Outperform · 🎯$31
Price at call : $17.85 — upside +74%
Today : $28.88 — upside +7%
Expected +74% · Actual -58% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-58.0%
stock -58% · XLV -12%
matured Aug 6, 25
▲ Overweight · 🎯$27
Price at call : $19.9 — upside +36%
Today : $28.88 — upside -7%
Expected +36% · Actual -60% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-59.9%
stock -60% · XLV -13%
matured Jul 31, 25
Raymond James ↗
Jun 14, 24
▲ Strong Buy · 🎯$40
Price at call : $19.52 — upside +105%
Today : $28.88 — upside +39%
Expected +105% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 39.9% · -2.0% (218 calls)
-53.6%
stock -54% · XLV -7%
matured Jun 14, 25
BMO Capital ↗
Jun 14, 24
▲ Outperform · 🎯$32
Price at call : $19.52 — upside +64%
Today : $28.88 — upside +11%
Expected +64% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (4 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-53.6%
stock -54% · XLV -7%
matured Jun 14, 25
RBC Capital ↗
Jun 14, 24
▲ Outperform · 🎯$31
Price at call : $19.52 — upside +59%
Today : $28.88 — upside +7%
Expected +59% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-53.6%
stock -54% · XLV -7%
matured Jun 14, 25
▲ Outperform · 🎯$36
Price at call : $21.34 — upside +69%
Today : $28.88 — upside +25%
Expected +69% · Actual -59% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 40% (5 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-58.9%
stock -59% · XLV -5%
matured May 10, 25
▲ Buy · 🎯$38
Price at call : $19.07 — upside +99%
Today : $28.88 — upside +32%
Expected +99% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 46.2% · +19.8% (65 calls)
-49.1%
stock -49% · XLV -2%
matured Apr 16, 25
Piper Sandler ↗
Feb 28, 24
■ Neutral neutral · not a buy · 🎯$24
Price at call : $22.95 — gap to target +5%
Today : $28.88 — gap to target -17%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Feb 27, 25
matures : Feb 27, 25
RBC Capital ↗
Feb 28, 24
▲ Outperform · 🎯$32
Price at call : $22.95 — upside +39%
Today : $28.88 — upside +11%
Expected +39% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-33.1%
stock -33% · XLV +3%
matured Feb 27, 25
BMO Capital ↗
Feb 28, 24
▲ Outperform · 🎯$34
Price at call : $22.79 — upside +49%
Today : $28.88 — upside +18%
Expected +49% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (4 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-34.3%
stock -34% · XLV +1%
matured Feb 27, 25
▲ Outperform · 🎯$34
Price at call : $22.79 — upside +49%
Today : $28.88 — upside +18%
Expected +49% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 40% (5 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-34.3%
stock -34% · XLV +1%
matured Feb 27, 25
▲ Buy · 🎯$50
Price at call : $20.02 — upside +150%
Today : $28.88 — upside +73%
Expected +150% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 100% (1 call matured) · 📊 on Health : 26.4% · -9.4% (87 calls)
+2.1%
stock +2% · XLV +2%
matured Jan 21, 25
Guggenheim ↗
Nov 8, 23
▲ Buy · 🎯$34
Price at call : $16.53 — upside +106%
Today : $28.88 — upside +18%
Expected +106% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 100% (1 call matured) · 📊 on Health : 67.3% · +19.3% (49 calls)
+42.9%
stock +43% · XLV +20%
matured Nov 7, 24
RBC Capital ↗
Nov 8, 23
▲ Outperform · 🎯$32
Price at call : $16.53 — upside +94%
Today : $28.88 — upside +11%
Expected +94% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+42.9%
stock +43% · XLV +20%
matured Nov 7, 24
▲ Outperform · 🎯$36
Price at call : $17.24 — upside +109%
Today : $28.88 — upside +25%
Expected +109% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 40% (5 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+34.4%
stock +34% · XLV +16%
matured Nov 7, 24
B of A Securities ↗
May 19, 23
▲ Buy · 🎯$42
Price at call : $27.45 — upside +53%
Today : $28.88 — upside +45%
Expected +53% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
-13.5%
stock -13% · XLV +11%
matured May 18, 24
RBC Capital ↗
May 9, 23
▲ Outperform · 🎯$36
Price at call : $26.89 — upside +34%
Today : $28.88 — upside +25%
Expected +34% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 29% (7 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-12.5%
stock -12% · XLV +8%
matured May 8, 24
▲ Outperform · 🎯$37
Price at call : $26.83 — upside +38%
Today : $28.88 — upside +28%
Expected +38% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 40% (5 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-11.8%
stock -12% · XLV +7%
matured May 8, 24
Canaccord Genuity ↗
Feb 24, 23
▲ Buy · 🎯$42
Price at call : $32.87 — upside +28%
Today : $28.88 — upside +45%
Expected +28% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 38.9% · -0.9% (144 calls)
-21.3%
stock -21% · XLV +15%
matured Feb 24, 24
EF Hutton
Feb 24, 23
▲ Buy · 🎯$42
Price at call : $33.13 — upside +27%
Today : $28.88 — upside +45%
Expected +27% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 unranked overall
-21.9%
stock -22% · XLV +14%
matured Feb 24, 24
Frequently asked questions
Should I buy Xencor Inc stock?
This isn't buy advice. For Xencor Inc, the analyst consensus is "Buy", with an average price target of $27.00 (-7% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Xencor Inc). We show the numbers — you decide.
Is it too late to buy Xencor Inc? How high can it go?
The most bullish analyst target on Xencor Inc is $44.00 (+52% above today's price); the average is $27.00. That's the upside they see. Check how reliable those analysts have actually been on Xencor Inc on our site before trusting it.
Is Xencor Inc still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 16 analysts have a real record on Xencor Inc, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Xencor Inc? The case for and against
The arguments for and against, one by one, from the numbers: why invest in XNCR (and why hesitate).
What has Xencor Inc's past performance been?
Historical returns and a "how much if I had invested" calculator: XNCR performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX